Dr. Rosalio Gallegos
What this data tells you about Dr. Gallegos
Dr. Rosalio Gallegos is a nurse practitioner - family in San Antonio, TX, with 6 years in practice. Based on federal Medicare data, Dr. Gallegos performed 166,539 Medicare services across 2,472 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gallegos received a total of $1,669 from 18 pharmaceutical and/or device companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gallegos is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 37,500 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 31,860 | $18 | $89 |
| Romosozumab injection (Evenity) for osteoporosis | 29,820 | $8 | $31 |
| Iron sucrose injection (Venofer) | 22,000 | $0 | $2 |
| Ocrelizumab infusion (Ocrevus) for MS | 14,400 | $34 | $123 |
| Vedolizumab infusion (Entyvio) | 12,000 | $16 | $79 |
| Injection, mepolizumab, 1 mg | 6,100 | $23 | $109 |
| Omalizumab injection (Xolair) for asthma/allergy | 4,665 | $30 | $134 |
| Infliximab infusion (Remicade) | 2,512 | $25 | $395 |
| Injection, rituximab, 10 mg | 1,450 | $59 | $315 |
| Injection, benralizumab, 1 mg | 750 | $132 | $596 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 698 | $47 | $300 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 629 | $40 | $250 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 445 | $13 | $125 |
| Drug injection, under skin or into muscle | 434 | $9 | $50 |
| Injection, zoledronic acid, 1 mg | 290 | $6 | $252 |
| New patient office visit (45-59 min) | 176 | $96 | $345 |
| Administration of chemotherapy into vein, 1 hour or less | 173 | $82 | $500 |
| Administration of chemotherapy into vein, each additional hour | 150 | $18 | $125 |
| Office visit, established patient (30-39 min) | 139 | $73 | $211 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 100 | $4 | $55 |
| Office visit, established patient (20-29 min) | 78 | $40 | $135 |
| Injection of additional new drug or substance into vein | 53 | $10 | $125 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 50 | $18 | $250 |
| Unclassified drugs | 32 | $7 | $26 |
| New patient office visit (30-44 min) | 21 | $72 | $245 |
| Injection, diphenhydramine hcl, up to 50 mg | 14 | $1 | $18 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
4.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gallegos is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (low-engagement, top 18%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gallegos experienced with iron infusion (injectafer)?
Does Dr. Gallegos receive payments from pharmaceutical companies?
How do Dr. Gallegos's costs compare to other nurse practitioner - familys in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology